Sickle Cell Awareness: The Power of Early Testing

Sickle cell anemia is an inherited blood disorder that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. This disorder causes red blood cells to become rigid and form into a sickle, or crescent, shape. The sickle-shaped cells die early, leaving an ongoing shortage of red blood cells. Complications can include serious infections, organ damage, and even strokes.

Screening Tests for Sickle Cell Anemia

Newborn Screening
All babies born in the United States are screened Sickle Cell Anemia Testing and Screening shortly after birth. A small blood sample is taken from the baby’s heel and tested. This newborn screening identifies babies with sickle cell anemia so they can receive follow-up care and treatment early on. Early diagnosis and treatment help prevent serious health problems.

Sickle Cell Anemia Testing and Screening-https://www.coherentmarketinsights.com/industry-reports/sickle-cell-anemia-testing-and-screening-market
Sickle Cell Awareness: The Power of Early Testing Sickle cell anemia is an inherited blood disorder that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. This disorder causes red blood cells to become rigid and form into a sickle, or crescent, shape. The sickle-shaped cells die early, leaving an ongoing shortage of red blood cells. Complications can include serious infections, organ damage, and even strokes. Screening Tests for Sickle Cell Anemia Newborn Screening All babies born in the United States are screened Sickle Cell Anemia Testing and Screening shortly after birth. A small blood sample is taken from the baby’s heel and tested. This newborn screening identifies babies with sickle cell anemia so they can receive follow-up care and treatment early on. Early diagnosis and treatment help prevent serious health problems. Sickle Cell Anemia Testing and Screening-https://www.coherentmarketinsights.com/industry-reports/sickle-cell-anemia-testing-and-screening-market
WWW.COHERENTMARKETINSIGHTS.COM
Sickle Cell Anemia Testing and Screening Market Share
Sickle Cell Anemia Testing and Screening Market is valued at USD 465.2 Mn in 2024, is anticipated to reaching USD 1,028.1 Mn by 2031, with a steady annual growth rate of 12%.
0 Comments 0 Shares 28 Views